Vectorite Biomedical Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 26.541 million compared to TWD 206.330 million a year ago. Operating loss was TWD 82.573 million compared to TWD 67.716 million a year ago. Net loss was TWD 90.269 million compared to TWD 30.323 million a year ago. Basic loss per share was TWD 2.14 compared to TWD 0.72 a year ago.